From: Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting
Variable
HR (CI 95%)
p
Age year (> 70 vs ≤ 70)
2.35 (1.026–5.396)
0.043
pT stage (pT2 vs pT1)
4.96 (1.99–12.38)
0.001
DD (high vs low)
3.17 (1.13–8.94)
0.029
FVIII (abnormal vs normal)
2.15 (0.90–5.15)
0.087